Last reviewed · How we verify
NCT05217056: GMs
Associations Between General Movements Assessments and Cognitive Development
trial testing measurements in Cerebral Palsy in 63 participants. Completed in 30 September 2021.
30 August 2021
Quick facts
| Lead sponsor | Kahramanmaras Sutcu Imam University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 63 |
| Start date | 1 August 2020 |
| Primary completion | 30 August 2021 |
| Estimated completion | 30 September 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- measurements
Conditions studied
- Cerebral Palsy — all drugs for Cerebral Palsy →
- Infant Development — all drugs for Infant Development →
- Cognitive Dysfunction — all drugs for Cognitive Dysfunction →
- Cognitive Developmental Delay — all drugs for Cognitive Developmental Delay →
Sponsor
Kahramanmaras Sutcu Imam University
Who can join
Adults 25 Weeks to 42 Weeks, any sex, with Cerebral Palsy or Infant Development. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
High risk infant is defined as infant with a negative history of environmental and biological factors, which can lead to neuromotor development problems. It is a heterogeneous group of premature infants born under thirty-seven weeks of age, with infants with low birth weight, term or developmental retardation for various reasons. Therefore, preterm infants with low birth weight can survive with a neurological sequelae such as cerebral palsy (CP), epilepsy, hearing and vision loss, mental retardation, speech and speech problems, and learning difficulties. The clinical diagnosis of CP and learning diffuculties which can be observed in high-risk infants, is based on the combination of some neurological and clinical signs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05217056
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebral Palsy
Currently open trials in the same condition.
- NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting
Other Kahramanmaras Sutcu Imam University trials
Trials by the same sponsor.
- NCT07511322 — Enteral Nutrition Education Provided Using the Pecha Kucha Method · enrolling by invitation
- NCT07515287 — Restoration of Sensorimotor Function in Middle-Aged Women With Chronic Lumbar Disc Herniation: The Effect of Pilates on · NA · enrolling by invitation
- NCT07451691 — The Effect of the World Health Organisation-Based Intrapartum Care Model on Labour Pain, Comfort, Satisfaction and Postp · NA · not yet recruiting
- NCT07471412 — Sexually Transmitted Infections in Migrant Women · NA · not yet recruiting
- NCT07332065 — The Effects of Mandala Coloring on Women During Menopause · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05217056 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kahramanmaras Sutcu Imam University
- Last refreshed: 1 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05217056.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing